IMO, that article reveals something HUGE!
ARIA was beaten down by shorts because it appeared ARIA just lost a substantial revenue stream. That article very strongly suggests that that is not the case, now.
Granted, Iclusig's future potential still remains to be seen, but at least ARIA's balance sheet won't be suffering nearly so much, and that is HUGE!
If ARIA would simply PR the new 'program' as issued by the FDA, there's a good fair chance ARIA could run back to $10+ on that alone.